Drug sensitivity and resistance testing identifies <scp>PLK</scp>1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors

Matthias Kolberg(Oslo University Hospital), Ragnhild A. Lothe(Oslo University Hospital)
Molecular Oncology
May 29, 2017
Cited by 23


Related Papers